How does desmopressin/DDAVP in von Willebrand disease (vWD)?

acts mechanistically by releasing transiently in patient plasma von Willebrand factor (vWF) and factor VIII (FVIII) from endothelial storage sites, thus being an autologous form of replacement therapy. Learn more here.